EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Timothy Schmidt, Zhubin Gahvari, Natalie S Callander

Clinical Lymphoma Myeloma and Leukemia · 2024

DOI: 10.1016/j.clml.2024.03.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Timothy Schmidt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, …. Hauptthemen laut MEDLINE: Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal proteins are common, with a prevalence in the United States around 5% and the incidence increases with age. Although most patients are asymptomatic, the vast majority of cases are caused by a clonal plasma cell disorder. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic precursor conditions with variable risk of progression to multiple myeloma (MM). In recent years, significant progress has been made to better understand the factors that lead to the development of symptoms and progression to myeloma. In this review, we summarize the current diagnosis treatment guidelines for MGUS and SMM and highlight recent advances that underscore a shifting paradigm in the evaluation and management of plasma cell precursor conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaHumansDisease ManagementDisease ProgressionMultiple Myeloma

Stichwörter der Autor:innen

MGUSMMRisk stratificationSMMScreening

Autor:innen und Institutionen

  • Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI.
  • Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI. Electronic address: nsc@medicine.wisc.edu.

Zitieren

APA

Schmidt, T., Gahvari, Z., & Callander, N. S. (2024). SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.03.008

Vancouver

Schmidt T, Gahvari Z, Callander NS. SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.03.008

BibTeX
@article{Schmidt2024,
  author = {Schmidt, Timothy and Gahvari, Zhubin and Callander, Natalie S},
  title = {SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  doi = {10.1016/j.clml.2024.03.008}
}
Kostenlos starten →